Gary A. King Insider Trading $MYGN MYRIAD GENETICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gary A. King.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gary A. King. Gary A. King is Exec. VP International Ops in MYRIAD GENETICS INC ($MYGN).
Gary A. King in MYRIAD GENETICS INC
Trading Symbol: MYGNIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Gary A. King: Exec. VP International Ops
Holdings: 151,724 shares
Current Value: $2,336,550
Latest Transaction: Oct 01 2019
$MYGN Market Capitalization: $1.13B
$MYGN Previous Close: $15.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Gary A. King in MYRIAD GENETICS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 28.63 | 3,327 | 95,252 | 148,397 | 151.7 K to 148.4 K (-2.19 %) |
Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 28.63 | 3,826 | 109,538 | 151,724 | 155.6 K to 151.7 K (-2.46 %) |
Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 28.63 | 3,327 | 95,252 | 148,397 | 151.7 K to 148.4 K (-2.19 %) |
Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 28.63 | 3,826 | 109,538 | 151,724 | 155.6 K to 151.7 K (-2.46 %) |
Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Grant | A | 0.00 | 27,000 | 0 | 155,550 | 128.6 K to 155.6 K (+21.00 %) |
Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 29.93 | 3,327 | 99,577 | 128,550 | 131.9 K to 128.6 K (-2.52 %) |
Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 29.93 | 2,994 | 89,610 | 131,877 | 134.9 K to 131.9 K (-2.22 %) |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 26.49 | 30,000 | 794,700 | 106,225 | |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 26.49 | 30,000 | 794,700 | 106,225 | |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 23.98 | 10,000 | 239,800 | 1,830 | |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 23.98 | 10,000 | 239,800 | 1,830 | |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 19.47 | 20,000 | 389,400 | 7,432 | |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 19.47 | 20,000 | 389,400 | 7,432 | |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 39.44 | 20,000 | 788,810 | 134,871 | 154.9 K to 134.9 K (-12.91 %) |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 39.44 | 20,000 | 788,810 | 134,871 | 154.9 K to 134.9 K (-12.91 %) |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 19.47 | 20,000 | 389,400 | 154,871 | 134.9 K to 154.9 K (+14.83 %) |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 19.47 | 20,000 | 389,400 | 154,871 | 134.9 K to 154.9 K (+14.83 %) |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 43.48 | 10,000 | 434,816 | 134,871 | 144.9 K to 134.9 K (-6.90 %) |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 43.48 | 10,000 | 434,816 | 134,871 | 144.9 K to 134.9 K (-6.90 %) |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 23.98 | 10,000 | 239,800 | 144,871 | 134.9 K to 144.9 K (+7.41 %) |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 23.98 | 10,000 | 239,800 | 144,871 | 134.9 K to 144.9 K (+7.41 %) |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 46.19 | 30,000 | 1,385,703 | 134,871 | 164.9 K to 134.9 K (-18.20 %) |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 46.19 | 30,000 | 1,385,703 | 134,871 | 164.9 K to 134.9 K (-18.20 %) |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 26.49 | 30,000 | 794,700 | 164,871 | 134.9 K to 164.9 K (+22.24 %) |
Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 26.49 | 30,000 | 794,700 | 164,871 | 134.9 K to 164.9 K (+22.24 %) |
Oct 02 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 46.00 | 3,327 | 153,042 | 133,973 | 137.3 K to 134 K (-2.42 %) |
Oct 02 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 46.00 | 3,826 | 175,996 | 137,300 | 141.1 K to 137.3 K (-2.71 %) |
Sep 26 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 46.65 | 3,327 | 155,205 | 141,126 | 144.5 K to 141.1 K (-2.30 %) |
Sep 21 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Grant | A | 0.00 | 27,000 | 0 | 144,453 | 117.5 K to 144.5 K (+22.99 %) |
Sep 18 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 46.35 | 5,101 | 236,431 | 117,453 | 122.6 K to 117.5 K (-4.16 %) |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 19.47 | 30,000 | 584,100 | 27,432 | |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 18.00 | 4,445 | 80,010 | 0 | |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 39.03 | 4,445 | 173,488 | 121,968 | 126.4 K to 122 K (-3.52 %) |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 18.00 | 4,445 | 80,010 | 126,413 | 122 K to 126.4 K (+3.64 %) |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 39.77 | 30,000 | 1,193,100 | 121,968 | 152 K to 122 K (-19.74 %) |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 19.47 | 30,000 | 584,100 | 151,968 | 122 K to 152 K (+24.60 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 36.18 | 3,522 | 127,426 | 121,917 | 125.4 K to 121.9 K (-2.81 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 36.18 | 4,050 | 146,529 | 125,439 | 129.5 K to 125.4 K (-3.13 %) |
Sep 19 2017 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 33.05 | 5,400 | 178,470 | 129,489 | 134.9 K to 129.5 K (-4.00 %) |
Sep 15 2017 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Grant | A | 0.00 | 30,000 | 0 | 134,889 | 104.9 K to 134.9 K (+28.60 %) |
Oct 03 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 20.58 | 4,050 | 83,349 | 103,449 | 107.5 K to 103.4 K (-3.77 %) |
Sep 20 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 20.92 | 3,721 | 77,843 | 107,499 | 111.2 K to 107.5 K (-3.35 %) |
Sep 16 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Grant | A | 0.00 | 30,000 | 0 | 111,220 | 81.2 K to 111.2 K (+36.94 %) |
Apr 05 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 14.88 | 15,000 | 223,200 | 3,120 | |
Apr 05 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 38.12 | 15,000 | 571,800 | 80,640 | 95.6 K to 80.6 K (-15.68 %) |
Apr 05 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 14.88 | 15,000 | 223,200 | 95,640 | 80.6 K to 95.6 K (+18.60 %) |
Apr 08 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 18.00 | 15,000 | 270,000 | 4,445 | |
Apr 08 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 39.03 | 15,000 | 585,450 | 80,640 | 95.6 K to 80.6 K (-15.68 %) |
Apr 08 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 18.00 | 15,000 | 270,000 | 95,640 | 80.6 K to 95.6 K (+18.60 %) |
Oct 28 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 23.98 | 10,000 | 239,800 | 11,830 | |
Oct 28 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 42.82 | 10,000 | 428,200 | 80,573 | 90.6 K to 80.6 K (-11.04 %) |
Oct 28 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 23.98 | 10,000 | 239,800 | 90,573 | 80.6 K to 90.6 K (+12.41 %) |
Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Payment of Exercise | F | 41.39 | 5,400 | 223,506 | 80,573 | 86 K to 80.6 K (-6.28 %) |
Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Grant | A | 0.00 | 34,500 | 0 | 85,973 | 51.5 K to 86 K (+67.03 %) |
Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Payment of Exercise | F | 41.39 | 5,400 | 223,506 | 80,573 | 86 K to 80.6 K (-6.28 %) |
Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Grant | A | 0.00 | 34,500 | 0 | 85,973 | 51.5 K to 86 K (+67.03 %) |
Sep 16 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 19.47 | 14,562 | 283,522 | 57,432 | |
Sep 16 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 39.41 | 14,562 | 573,888 | 51,473 | 66 K to 51.5 K (-22.05 %) |
Sep 16 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 19.47 | 14,562 | 283,522 | 66,035 | 51.5 K to 66 K (+28.29 %) |
Sep 08 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 19.47 | 25,438 | 495,278 | 71,994 | |
Sep 08 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 39.41 | 25,438 | 1,002,512 | 51,473 | 76.9 K to 51.5 K (-33.07 %) |
Sep 08 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 19.47 | 25,438 | 495,278 | 76,911 | 51.5 K to 76.9 K (+49.42 %) |
Sep 02 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 18.00 | 15,000 | 270,000 | 19,445 | |
Sep 02 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 38.23 | 15,000 | 573,450 | 51,473 | 66.5 K to 51.5 K (-22.57 %) |
Sep 02 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 18.00 | 15,000 | 270,000 | 66,473 | 51.5 K to 66.5 K (+29.14 %) |
Aug 31 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 14.88 | 30,000 | 446,400 | 18,120 | |
Aug 31 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 35.73 | 30,000 | 1,071,900 | 51,473 | 81.5 K to 51.5 K (-36.82 %) |
Aug 31 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 14.88 | 30,000 | 446,400 | 81,473 | 51.5 K to 81.5 K (+58.28 %) |
Nov 05 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 19.47 | 6,568 | 127,879 | 97,432 | |
Nov 05 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 39.95 | 6,568 | 262,392 | 50,698 | 57.3 K to 50.7 K (-11.47 %) |
Nov 05 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 19.47 | 6,568 | 127,879 | 57,266 | 50.7 K to 57.3 K (+12.96 %) |
Sep 18 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Grant | A | 0.00 | 46,000 | 0 | 50,698 | 4.7 K to 50.7 K (+979.14 %) |
Feb 24 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 18.00 | 20,000 | 360,000 | 34,445 | |
Feb 24 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 38.00 | 20,000 | 760,000 | 2,949 | 22.9 K to 2.9 K (-87.15 %) |
Feb 24 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 18.00 | 20,000 | 360,000 | 22,949 | 2.9 K to 22.9 K (+678.20 %) |
Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 14.88 | 25,000 | 372,000 | 48,120 | |
Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 34.74 | 25,000 | 868,550 | 2,949 | 27.9 K to 2.9 K (-89.45 %) |
Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 14.88 | 25,000 | 372,000 | 27,949 | 2.9 K to 27.9 K (+847.74 %) |
Sep 19 2013 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | A | 26.49 | 136,225 | 3,608,600 | 136,225 | |
Sep 19 2013 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | A | 26.49 | 3,775 | 100,000 | 3,775 | |
Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | A | 27.07 | 130,000 | 3,519,100 | 130,000 | |
Mar 08 2012 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | A | 23.98 | 21,830 | 523,483 | 21,830 | |
Mar 08 2012 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | A | 23.98 | 4,170 | 99,997 | 4,170 | |
Sep 15 2011 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | A | 19.47 | 104,000 | 2,024,880 | 104,000 | |
Feb 24 2011 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | A | 18.00 | 54,445 | 980,010 | 54,445 | |
Feb 24 2011 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | A | 18.00 | 5,555 | 99,990 | 5,555 | |
Aug 04 2010 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | A | 14.88 | 73,120 | 1,088,026 | 73,120 | |
Aug 04 2010 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | A | 14.88 | 26,880 | 399,974 | 26,880 |
Page: 1